+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Sarcoma Drug"

Soft Tissue Sarcoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Soft Tissue Sarcoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Synovial Sarcoma Market Report and Forecast 2024-2032 - Product Thumbnail Image

Synovial Sarcoma Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
From
From
From
From
From
Kaposi Sarcoma Market 2021-2025 - Product Thumbnail Image

Kaposi Sarcoma Market 2021-2025

  • Report
  • February 2021
  • 120 Pages
  • Global
From
Ewing Sarcoma Disease - Global Clinical Trials Review, H1, 2021 - Product Thumbnail Image

Ewing Sarcoma Disease - Global Clinical Trials Review, H1, 2021

  • Clinical Trials
  • February 2021
  • 267 Pages
  • Global
From
From
From
From
From
From
From
From
From
Loading Indicator

Sarcoma is a type of cancer that affects the connective tissues of the body, such as muscle, bone, fat, and blood vessels. Sarcoma drugs are used to treat this type of cancer, and are part of the larger oncology drug market. These drugs are typically used in combination with other treatments, such as surgery, radiation, and chemotherapy. Sarcoma drugs are designed to target the specific type of cancer, and can be used to reduce the size of tumors, slow the growth of cancer cells, and reduce the risk of metastasis. The sarcoma drug market is highly competitive, with many companies developing new treatments and therapies. Some of the major players in the market include Pfizer, Merck, Novartis, Bristol-Myers Squibb, and Eli Lilly. Other companies, such as Amgen, AstraZeneca, and Celgene, are also developing treatments for sarcoma. Show Less Read more